Literature DB >> 7105059

Phase II trial of etoposide in the management of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.

R E Slayton, J A Blessing, G Delgado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7105059

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma.

Authors:  Brian M Slomovitz; Yunyun Jiang; Melinda S Yates; Pamela T Soliman; Taren Johnston; Maureen Nowakowski; Charles Levenback; Qian Zhang; Kari Ring; Mark F Munsell; David M Gershenson; Karen H Lu; Robert L Coleman
Journal:  J Clin Oncol       Date:  2015-01-26       Impact factor: 44.544

3.  Phase II trial of docetaxel in advanced or metastatic endometrial cancer: a Japanese Cooperative Study.

Authors:  N Katsumata; K Noda; S Nozawa; R Kitagawa; R Nishimura; S Yamaguchi; D Aoki; N Susumu; H Kuramoto; T Jobo; K Ueki; M Ueki; I Kohno; K Fujiwara; Y Sohda; F Eguchi
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

Review 4.  Recent advances in endometrial cancer: a review of key clinical trials from 2015 to 2019.

Authors:  Lindsey M Charo; Steven C Plaxe
Journal:  F1000Res       Date:  2019-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.